Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026

Get updates on Theralase Technologies Inc. delivered in your email.

Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > *DON’T WORRY ~ BE HAPPY*

View:

Post by skyhawk1 on Apr 06, 2022 9:54am

DON’T WORRY ~ BE HAPPY

I know that it hard to stay SUPER positive without any doubts creeping in, after yesterday's major HICCUP but we 'super longs' must remain steadfast & stay the course to the FINISH line!

Don't get takin' in by the market manipulators. After yesterday's NR ~ it's very clear NOW that we have come a long ways & much further ahead!

This remarkable SCIENCE is still there & it WORKS very well. If anything it's time to NIBBLE away with any accessible DRY POWDER?!

Isn't that y most of us r here? To eventually make the big money payday & to SAVE lives!

GOOD THINGS COME TO THOSE WHO WAIT!! We gotta c TLD-1433 to FRUITION.

G'day super longs & freedom loving patriots! Time for some very early & cold TEE time. Heheh ~ Cheers ~

185

Comment

Comment by Rumpl3StiltSkin on Apr 06, 2022 9:57am

Right On Skyhawk! TLT is on sale folks. Some evil traders engineered a flash crash yesterday, I believe. Maybe not the Cure for Cancer but definetly a treatent is cheap .33c CAD!! GL :-)

125

Comment

Theralase Technologies Inc.

The Market Update

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

Connect with V.TLT

INVESTORS & MEDIA OVERVIEW FINANCIAL FILINGS PRESENTATIONS MEDIA FACT SHEETS MANAGEMENT

Investor Presentation

The Road to Saving Lives: Clinical Study Underway

Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
Best-in-class treatment for NMIBC (according to interim clinical data)
NMIBC (Non-Muscle-Invasive Bladder Cancer)

FACT SHEET

The Watchlist

< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
Best-in-class treatment for NMIBC (according to interim clinical data)
NMIBC (Non-Muscle-Invasive Bladder Cancer)

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250

Become a member today, It's free!

Sign In

Send my password